NCT01456689View on ClinicalTrials.gov

A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

April 25, 2012

Primary Completion Date

June 5, 2019

Study Completion Date

June 5, 2019

Conditions
Multiple Myeloma
Interventions
DRUG

LGH447

DRUG

midazolam

Trial Locations (8)

24105

Novartis Investigative Site, Kiel

37007

Novartis Investigative Site, Salamanca

48109

Novartis Investigative Site, Ann Arbor

55905

Novartis Investigative Site, Rochester

60637

Novartis Investigative Site, Chicago

69120

Novartis Investigative Site, Heidelberg

77030

Novartis Investigative Site, Houston

169608

Novartis Investigative Site, Singapore

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY